As Horizon works to beef up drug sales, CEO Walbert maps a big manufacturing expansion in Ireland, 350 new jobs
Horizon Therapeutics is planning a big expansion at its drug development and manufacturing site in Ireland.
Right in the wake of mapping out plans to spur bigger sales of Tepezza after a disappointing launch, Horizon chief Tim Walbert says they’ve blueprinted a 320,000-square-foot expansion to the 44,000-square-foot facility they acquired in Waterford last summer for $65 million. And they’ll tie that to up to 350 new hires as Ireland enjoys a fresh surge of deals in the drug manufacturing sector.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,800+ biopharma pros reading Endpoints daily — and it's free.